The Link in Global Manufacturing – SST Corporation is your provider of choice for APIs and pharmaceutical services. We represent CMO’s / CDMO’s and manufacturers of Active Pharmaceutical Ingredients from around the world. SST Corporation is the leading supplier of active pharmaceutical ingredients (APIs). We have been in operation for over 75 consecutive years and are engaged in sourcing and sales of API’s, regulatory support services, Nitrosamine Testing, RLD sourcing, DEA Import Services, logistics and customer service. SST has an expansive global supplier network that consists of dozens of companies. These organizations all have expertise in pharmaceutical manufacturing and impeccable compliance history. Many of them have decades-long standing relationships with SST, with an established track record of successfully serving our customers. In January 2025, SST acquired the business operations of MediPharm International Consultants, Ltd., now “MediPharm International”. MediPharm is a well-established, global regulatory service organization providing technical, regulatory consultation and guidance services for the pharmaceutical and medical device industries. MediPharm has more than 30 years of experience in the pharmaceutical industry successfully preparing domestic and international clients manufacturing both active pharmaceutical ingredients and finished dosage forms for FDA Pre-Approval Inspections (PAI), directing clients in the preparation of Standard Operating Procedure (SOP) and Quality System Manuals, Quality Agreements, and Corrective and Preventative Action (CAPA) Programs. In January 2025, SST signed an exclusive license agreement for the US and Canadian rights to BuddyDrops from i+Med S. Coop. BuddyDrops is a long-lasting, moisturizing and lubricating eye drop that helps to moisturize and maintain your pet’s eye hygiene. Thanks to a unique combination of ingredients and sustained release technology, BuddyDrops remain on the surface of the eye for up to 12 hours, reducing the need and frequency of application. SST Corporation advantages: provider of pharmaceutical products and services tailored to your needs – Collaboration from expert to expert – US headquartered, with a global operational network reach. Accelerate your business and benefit from our expertise and tailored pharmaceutical support to safeguard your project executions – from drug development to commercial phase.
Profarma
Europe based EU GMP certified and MIA License holding Laboratory ensuring patient safety by testing pharmaceutical products, developing new medicines, and performing QP batch release to the EU market together with pharma manufacturers and distributors. Profarma‘s expertise includes small molecules, peptides, and biologics, including active pharmaceutical ingredients (API), intermediate stages, and final drug products. Our clients come to us at different stages of drug product life cycle starting from early development, drug registration to routine commercial supply for EU market. We help to assure products quality and open doors to complex European markets. | Europe based EU GMP certified and MIA License holding Laboratory ensuring patient safety by testing pharmaceutical products, developing new medicines, and performing QP batch release to the EU market together with pharma manufacturers and distributors.
Prince Sterilization Services
Prince Sterilization Services is the leading contract sterilization service provider specializing in moist heat steam, low-temperature vaporized hydrogen peroxide, pre-filled syringes, dry heat sterilization and depyrogenation services. With decades of expertise and state-of-the-art facilities and equipment, Prince is positioned to support medical device and pharmaceutical customers’ packaging, washing, and sterilization needs from development to commercialization. Operating in over 50,000 square feet of cGMP space, we ensure FDA and ISO 13485 compliance while prioritizing sustainability. All of Prince’s Contract Sterilization solutions satisfy cGMP while being the eco-friendliest, nontoxic, and sustainable modalities available. Prince is also a supplier of Ready-to-Use (RTU) vials, stoppers, seals, bottles, and other pharmaceutical and pharmacy drug product components. All processing of materials, including inspection, washing, depyrogenation/sterilization, and final packaging, is performed in ISO certified clean rooms. Water for injection (WFI) that meets USP and EN285 standards is used for all critical processes, including vial washers, component washers, and steam sterilizers. Prince is a leading provider of terminal sterilization for a variety of healthcare products, including medical devices, single-use bottles, and tubing sets, stainless steel components, APIs, filled drug products in vials, syringes, and IV bags, and many other materials and products. Our technical staff is ready to provide case-by-case consultation support when needed. Explore our comprehensive sterilization services at www.princesterilization.com or connect with us directly at info@princesterilization.com. | Prince Sterilization Services (Prince) is a trusted partner to the medical device, pharmaceutical, and broader life sciences industries as a premier provider of contract sterilization modalities, including steam, low-temperature vaporized hydrogen peroxide (VH2O2), and dry heat sterilization services, and sterile, ready-to-use (RTU) custom components. A third-generation business built on quality, technical confidence, and care; Prince delivers comprehensive contract sterilization services, ready-to-use components (RTU), and cleanroom kitting and packaging solutions from our FDA-registered, CGMP-compliant, and ISO 13485-certified facilities. Prince’s New Jersey campus spans over 100,000 ft² of GMP manufacturing, warehousing, and administrative space, equipped with full-facility backup generators. Prince is an industry-leading provider of ready-to-use vials, stoppers, seals, and sterile components. Take a virtual tour of the NJ campus at https://princesterilization.com. Reach our technical experts at info@princesterilization.com.
Polpharma Biologics S.A.
Polpharma Biologics is an international biotechnology company with integrated operations in the European Union, developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production ready to be commercialized by our partners in all major pharmaceutical markets. The company’s expertise is in the development and manufacturing of medicines based on microbial & mammalian expression. Company is currently developing 10 molecules and in addition, have 2 biosimilars approved in multiple markets. These leading biosimilars are partnered with multiple companies for marketing rights to different territories.
PiSA Farmacéutica
PiSA® Farmaceutica is a Mexican company with almost 80 years of history dedicated to the manufacturing, marketing and distribution of health product. Our portfolio consists in more than 1,500 brands of medicines distributed through 17 therapeutic areas. Currently, we are a team with over 27,000 collaborators dedicated to health care throughout the American continent. Hold the Electrolit®️ brand which is the 4th biggest brand in Hydration and Isotonic beverages category and has a presence in 14 countries. Now available in Europe (Spain). We have our own network of 7 warehouses throughout the country and a fleet of 400 units, making us the best partner and supplier to healthcare organizations, as we are fully integrated into the future, including last mile distribution. Committed to offering high quality products, we have certifications in: • Good Manufacturing Practices in accordance with NOM 241 SSA1-2012 (MEX) • ISO 9001 and ISO 13485 • FDA for Medical Devices • INVIMA • Shingo Prize Silver Medallion The growth at PiSA®️ Farmacéutica has been a constant due to its human capital. We are committed to excellence, aware that each of our actions and activities are to fulfill our reason for being: “A Life at the Service of Life.” | Laboratorios PiSA® PiSA® Farmaceutica is a Mexican company with almost 80 years of history dedicated to the manufacturing, marketing and distribution of health product. Our portfolio consists in more than 1,500 brands of medicines distributed through 17 therapeutic areas. Currently, we are a team with over 27,000 collaborators dedicated to health care throughout the American continent. Hold the Electrolit®️ brand which is the 4th biggest brand in Hydration and Isotonic beverages category and has a presence in 14 countries. Now available in Europe (Spain). We have our own network of 7 warehouses throughout the country and a fleet of 400 units, making us the best partner and supplier to healthcare organizations, as we are fully integrated into the future, including last mile distribution. Committed to offering high quality products, we have certifications in: • Good Manufacturing Practices in accordance with NOM 241 SSA1-2012 (MEX) • ISO 9001 and ISO 13485 • FDA for Medical Devices • INVIMA • Shingo Prize Silver Medallion The growth at PiSA®️ Farmacéutica has been a constant due to its human capital. We are committed to excellence, aware that each of our actions and activities are to fulfill our reason for being: “A Life at the Service of Life.”
Piramal Pharma Solutions
PPS is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product.PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited’s investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies makes us a partner of choice for innovator and generic companies worldwide. | Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products and services, and potent solid oral drug products. PPS also offers development and manufacturing services for biologics including vaccines and gene therapies, made possible through Piramal Pharma Limited’s associate company, Yapan Bio Private Limited.
PharSafer
Founded in 2003 by Dr Graeme Ladds, PharSafer® is a specialist Contract Research Organisation (CRO) in Global Clinical and Post Marketing Drug Safety, and Medical Services, with a wealth of experience in Pharmacovigilance, Auditing and Medical Affairs – and the various, numerous and extensive legal safety/medical obligations for licence holders to comply with – as well as Regulatory Strategy for the best methods for obtaining scientific advice concerning licence submissions and approvals. Together with our sister company which focuses on Training: SaPhar, PharSafer® continuously seeks new and innovative ways to provide added value for our global clients – going above and beyond expectations and optimising processes and procedures involved with clinical and post marketing drug safety and licencing approach. Our ability to offer first-class services in Pharmacovigilance, Regulatory Affairs, Training, Auditing, Medical Affairs and IT Informatics means that, for many clients, we operate as their Pharmacovigilance and Medical Departments – guiding them through the labyrinth of drug safety and medical legislation, all in the interests of ensuring patient safety and client compliance. We love what we do. We love finding solutions. Quite simply, we are by far… Your leading partner in Drug Safety. | PharSafer is a Global CRO specialising in Clinical & Post Marketing Pharmacovigilance; Medical Affairs; Training; Auditing; IT Informatics and Regulatory Intelligence. PharSafer have been operating for the last 23 years growing annually and helping take Companies from their clinical to post-marketing phases and many clients have been with us over 10 years now. PharSafer have attended over 100 inspections on behalf of clients to aid their compliance and ensure Regulatory Authorities are satisfied with the activities being performed. PharSafer are also an innovative Company designing validated and automated systems to provide cost-effective solutions for clients and ensure Regulatory compliant systems. Our client base is truly global being in all continents and for clients that have drugs; devices; vaccines; biologics; advanced therapies; biosimilars; herbal and cosmetics. Our Team within the Company are very experienced (many with over 15 years experience) aided by our sister training Company (SaPhar) to provide new updates for clients on country specific regulations with regular monthly contacts and comments going to all clients. We would be happy to engage with you and talk about product development; product expansions into new countries; product launches and perform all of the activities mentioned above. Please review of website and we look forward to engaging with you personally.